Scientists have solved a decades-old medical mystery by finally identifying a previously unknown molecule which is attacked by the immune system in people with Type 1 diabetes.
The current test is only able to analyze part of the human immune system, namely the B-cells but not the T-cells.
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses.
Canadian pharmaceutical company Valeant named Joseph Papa as its new chief executive and chairman on Monday.
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Heroin and opioid painkiller abuse is a growing, deadly problem that has become a top political issue in many states.
Photodynamic therapy (PDT) in medicine usually uses a substance that reacts to light and converts the oxygen in the tissue into aggressive radicals.
The findings could enhance vaccines and make them much more effective.
The treatment was originally intended to demonstrate the safety of the latest generation of the therapies.
Harvard Medical School scientists have found a compound that in laboratory dishes blocks the dengue virus in two ways.
How has this widely acclaimed biomedical innovator fallen so far, so fast?
It is estimated that almost 600,000 Canadians will experience anaphylaxis in their lifetime and that more than half of the individuals who had anaphylaxis were not equipped with life-saving epinephrine.
Chemists have long dreamed of using similarly cheap and easy techniques to make carbon-to-carbon couplings.
Lawmakers in states across the country have considered or adopted secrecy laws to help ensure a steady supply of lethal injection drugs.